Table 3.
Characteristics of the study population (1).
| Age, years |
Female (%) |
Diabetes (%) |
Smoking (%) |
Hypertension (%) |
COPD (%) |
CKD (%) |
Previous MI (%) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | HCR | PCI | HCR | PCI | HCR | PCI | HCR | PCI | HCR | PCI | HCR | PCI | HCR | PCI | HCR | PCI |
| Hannan 2021 | NR | NR | 21.5 | 28.6 | 35.5 | 34.0 | NR | NR | NR | NR | 4.8 | 5.7 | 3.6 | 4.0 | 17.0 | 19.3 |
| Basman 2020 | 67.5 ± 10.1 | 67.8 ± 10.5 | 16 | 16 | 53 | 50 | NR | NR | NR | NR | 2 | 0 | 3 | 3 | 28 | 29 |
| Ganyukov 2020 | 62 ± 7.4 | 61.7 ± 7.7 | 25 | 30.2 | 17.3 | 20.7 | 46.1 | 47.2 | 65.4 | 67.9 | 7.7 | 11.3 | 1.9 | 5.7 | 51.9 | 58.5 |
| Qiu 2019 | 64.6 ± 8.3 | 65.0 ± 9.8 | 14.9 | 25.5 | 40.4 | 46.8 | 51.1 | 31.9 | 61.7 | 72.3 | 0 | 2.1 | NR | NR | 25.5 | 38.3 |
| Repossini 2018 | 68 0.0 ± 9.0 | 69.0 ± 11.0 | 22.7 | 24.8 | 26.8 | 30.8 | NR | NR | 66.4 | 64.7 | 19.3 | 19.9 | 16.5 | 17.9 | 28.2 | 29.5 |
| Puskas 2016 | 64.4 ± 11.8 | 63.9 ± 10.8 | 24 | 28.6 | 39.5 | 36.7 | NR | NR | NR | NR | 9 | 12.3 | NR | NR | 37 | 23.5 |
| Shen 2013 | 62.0 ± 9.9 | 61.7 ± 10.3 | 11.3 | 12.8 | 26.2 | 19.9 | 55.3 | 24.8 | 64.5 | 59.6 | 7.1 | 7.8 | 2.8 | 5.0 | 27.7 | 27.7 |
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HCR, hybrid coronary revascularization; MI, myocardial revascularization; NR, not reported; PCI, percutaneous coronary intervention.